Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Efficacy Comparison of DExamethasone Intravitreal Implant Combined With Aflibercept Versus Aflibercept Monotherapy in Treatment-naïve Inflammatory Diabetic Macular Edema Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial protocol comparing dexamethasone intravitreal implant combined with aflibercept versus aflibercept monotherapy in treatment-naïve infla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EYLEA (Aflibercept)
  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Kun Liu | Conditions: Diabetic Macular Edema (DME) | Phase 4 | Status: NOT_YET_RECRUITING